TRI MIX 13/30/0.8 5ML MDV MCG/MG/MG/ML INJ, Injection, 13mcg/30mg/0.8mg/mL, RX only, 5 mL Glass/M...

FDA Recall #D-0740-2017 — Class II — April 18, 2017

Recall #D-0740-2017 Date: April 18, 2017 Classification: Class II Status: Terminated

Product Description

TRI MIX 13/30/0.8 5ML MDV MCG/MG/MG/ML INJ, Injection, 13mcg/30mg/0.8mg/mL, RX only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

Reason for Recall

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Recalling Firm

Key Pharmacy and Compounding Center — Federal Way, WA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1 vial

Distribution

Distributed nationwide in U.S.A., Australia and Canada.

Code Information

Lot # t01-31-2017@127, Exp 7/5/2017

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated